Effect of Insulin Therapy using Hyper-insulinemic Normoglycemic Clamp on Inflammatory Response in Brain Dead Organ Donors.
暂无分享,去创建一个
T. Nouh | M. Aljiffry | P. Metrakos | M. Hassanain | T. Schricker | L. Wykes | R. Lattermann | M. Shaheen | A. Salman
[1] A. Hartmann,et al. Early Posttransplantation Hyperglycemia in Kidney Transplant Recipients Is Associated With Overall Long-term Graft Losses , 2012, Transplantation.
[2] J. Bugge. Brain death and its implications for management of the potential organ donor , 2009, Acta anaesthesiologica Scandinavica.
[3] G. Paolisso,et al. Tight glycemic control reduces heart inflammation and remodeling during acute myocardial infarction in hyperglycemic patients. , 2009, Journal of the American College of Cardiology.
[4] A. Barklin,et al. Systemic inflammation in the brain‐dead organ donor , 2009, Acta anaesthesiologica Scandinavica.
[5] P. Neuhaus,et al. Methylprednisolone Therapy in Deceased Donors Reduces Inflammation in the Donor Liver and Improves Outcome After Liver Transplantation: A Prospective Randomized Controlled Trial , 2008, Annals of surgery.
[6] P. Metrakos,et al. Hepatic protection by perioperative metabolic support? , 2008, Nutrition.
[7] K. Lachapelle,et al. High-dose insulin therapy attenuates systemic inflammatory response in coronary artery bypass grafting patients. , 2008, The Annals of thoracic surgery.
[8] J. Kellum,et al. Increased plasma interleukin-6 in donors is associated with lower recipient hospital-free survival after cadaveric organ transplantation* , 2008, Critical care medicine.
[9] O. Schmitz,et al. Insulin alters cytokine content in two pivotal organs after brain death: a porcine model , 2008, Acta anaesthesiologica Scandinavica.
[10] M. Miyazaki,et al. Poor postoperative blood glucose control increases surgical site infections after surgery for hepato-biliary-pancreatic cancer: a prospective study in a high-volume institute in Japan. , 2008, The Journal of hospital infection.
[11] G. Choukroun,et al. Insulin maintains plasma antioxidant capacity at an early phase of kidney transplantation. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[12] G. Hotamisligil,et al. Inflammation and metabolic disorders , 2006, Nature.
[13] D. Fry,et al. Acute hyperglycemia and the innate immune system: Clinical, cellular, and molecular aspects , 2005, Critical care medicine.
[14] P. Neuhaus,et al. What can be learned from brain‐death models? , 2005, Transplant international : official journal of the European Society for Organ Transplantation.
[15] F. Delmonico,et al. Aggressive pharmacologic donor management results in more transplanted organs1 , 2003, Transplantation.
[16] Y. Hwang,et al. Hepatocyte protection by a protease inhibitor against ischemia/reperfusion injury of human liver. , 2002, Journal of the American College of Surgeons.
[17] K. Hoya,et al. Acute Systemic Inflammatory Response Syndrome in Subarachnoid Hemorrhage , 2001, Stroke.
[18] T. Billiar,et al. Molecular mechanisms in the early phase of hemorrhagic shock , 2001, Langenbeck’s Archives of Surgery.
[19] M. Wilhelm,et al. Early and late inflammatory changes occurring in rat renal isografts from brain dead donors. , 2001, Transplantation proceedings.
[20] D. Pinsky,et al. The endothelial response to oxygen deprivation: biology and clinical implications , 2001, Intensive Care Medicine.
[21] M. Yacoub,et al. Elevated Tumor Necrosis Factor-&agr; and Interleukin-6 in Myocardium and Serum of Malfunctioning Donor Hearts , 2000, Circulation.
[22] A. Khaghani,et al. Tumor necrosis factor-alpha is expressed in donor heart and predicts right ventricular failure after human heart transplantation. , 2000, Circulation.
[23] S. Fuggle,et al. Cadaver versus living donor kidneys: impact of donor factors on antigen induction before transplantation. , 1999, Kidney international.
[24] P. Corris,et al. Enhanced pulmonary inflammation in organ donors following fatal non-traumatic brain injury , 1999, The Lancet.
[25] D. V. van Thiel,et al. Ischemia‐reperfusion injury in rat fatty liver: Role of nutritional status , 1999, Hepatology.
[26] D. Salant,et al. RANTES and Monocyte Chemoattractant Protein–1 (MCP-1) Play an Important Role in the Inflammatory Phase of Crescentic Nephritis, but Only MCP-1 Is Involved in Crescent Formation and Interstitial Fibrosis , 1997, The Journal of experimental medicine.
[27] O. Ljungqvist,et al. Pre-stress carbohydrate solution prevents fatal outcome after hemorrhage in 24-hour food-deprived rats. , 1996, Nutrition.
[28] G. Breithardt,et al. The relation of interleukin-6, tumor necrosis factor-alpha, IL-2, and IL-2 receptor levels to cellular rejection, allograft dysfunction, and clinical events early after cardiac transplantation. , 1995, Transplantation.
[29] C. McClain,et al. Cytokines and metabolic dysfunction after severe head injury. , 1994, Journal of neurotrauma.
[30] D. L. Le Couteur,et al. The effects of aging and nutritional state on hypoxia-reoxygenation injury in the perfused rat liver. , 1994, Transplantation.
[31] M. Lindholm. Critically ill patients and fat emulsions. , 1992, Minerva anestesiologica.
[32] H. Bismuth,et al. High levels of glycogen in the donor liver improve survival after liver transplantation in rats. , 1991, Transplantation proceedings.
[33] K. Cianflone,et al. High-dose insulin therapy reduces postoperative liver dysfunction and complications in liver resection patients through reduced apoptosis and altered inflammation. , 2012, The Journal of clinical endocrinology and metabolism.
[34] G. V. Berghe,et al. Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.
[35] T. Stanford. The potential organ donor. , 1986, Emergency.